talazoparib,enzalutamide
pfizer,astellas
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
 excellent discussion about parpi in prostate cancer. these are the exact points for discussion before regulatory approval of parp for hrr negative patients! #gu23 
Associate Oncologist Sirio Libanes Hospital, Sao Paulo Head of Clinical Research in Oncology, Sirio Libanes Hospital Scientific Director LACOG, Genitourinary